In 2004, early-stage stomach cancer, also called gastric cancer. was detected at a rate of 1.94 per 100,000. By 2021, that number had risen to 2.97 per 100,000.

Notably, overall incidence of early or localized gastric cancer increased approximately 53% from 2004 to 2021 — from 1.94 per 100,000 to 2.97 per 100,000 — while incidence of regional ...

A low prognostic nutritional index is associated with an increased risk for 90-day mortality and adverse postoperative ...

While stomach cancer isn't a leading cause of cancer incidence and death in the United States or Europe, it is a major cause of cancer and mortality throughout Asia, including Japan.

A pioneering study has revealed new insights into the role of gastric bacteria in stomach cancer development that could pave the way for a more effective treatment of pre-cancer.

Clinicians can help reduce gastric cancer incidence and mortality in high-risk groups through endoscopic screening and surveillance of precancerous conditions, such as gastric intestinal ...

HLX22's orphan drug designation for gastric cancer recognizes its potential benefit and marks a milestone following the launch of its global phase 3 clinical trials, according to the release. HLX22-GC ...

In Singapore, gastric cancer ranks among the top 10 causes of cancer-related deaths and claims about 300 lives each year. Combining state-of-the-art spatial technologies and genetic engineering tools ...

Stomach cancer has limited treatment options and poor survival rates. Better approaches are needed to find it earlier, and offer treatment when it is more likely to be successful.